Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia Read more about Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts Read more about Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines Read more about Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference Read more about Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference Synlogic Reports Third Quarter 2018 Financial Results and Provides Program Updates Read more about Synlogic Reports Third Quarter 2018 Financial Results and Provides Program Updates Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) Read more about Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) Synlogic Announces Third Quarter 2018 Conference Call and Webcast Read more about Synlogic Announces Third Quarter 2018 Conference Call and Webcast Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting Read more about Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting Read more about Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer Read more about Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer Pagination First page « First Previous page ‹ Previous … Page 13 Page 14 Page 15 Page 16 Current page 17 Page 18 Page 19 Page 20 Page 21 … Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia Read more about Science Translational Medicine Publishes First-in-Human Clinical Data and Supporting Preclinical Data for SYNB1020, Synlogic’s Synthetic Biotic™ Medicine in Development as a Potential Treatment for Hyperammonemia
Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts Read more about Synlogic Progresses Clinical and Preclinical Pipeline and Outlines 2019 Catalysts
Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines Read more about Synlogic Expands Capabilities in Manufacturing with the Appointment of Head of Technical Operations and Establishment of In-house Production of Clinical Trial Material for its Synthetic BioticTM Medicines
Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference Read more about Synlogic to Webcast Presentation at the 30th Annual Piper Jaffray Healthcare Conference
Synlogic Reports Third Quarter 2018 Financial Results and Provides Program Updates Read more about Synlogic Reports Third Quarter 2018 Financial Results and Provides Program Updates
Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD) Read more about Synlogic Presents Data at the 2018 Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Disease (AASLD)
Synlogic Announces Third Quarter 2018 Conference Call and Webcast Read more about Synlogic Announces Third Quarter 2018 Conference Call and Webcast
Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting Read more about Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting Read more about Synlogic to Host Analyst & Investor Event at the Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting
Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer Read more about Synlogic Appoints Dr. Aoife Brennan as President and Chief Executive Officer